Clinical Trial Update: A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms [Phase 3]

View source ↗

Summary

AMZ001 is being evaluated in a Phase 3 trial for knee osteoarthritis and the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Osteoarthritis of Knee

Drugs mentioned

• AMZ001

Snippet

Sponsor: Amzell | Conditions: Osteoarthritis of Knee, Osteoarthritis, Knee | Phase 3 | Status: ACTIVE_NOT_RECRUITING